Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-03-14 @ 8:40 PM
Study NCT ID:
NCT02889328
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2016-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
Sponsor:
Asan Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Stromal Tumors (GISTs) | View |
Keywords: